Clinical Trial Update: Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports termination of a Phase 1/2 study of lepirudin in patients with recurrent or advanced small cell lung cancer and notes that re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Lepirudin (lepirudin)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-08-08